DEF 14AThe Ballot
Janux Therapeutics, Inc. files DEF 14A
Filed Apr 28, 2023 · 3y ago · Accession 0000950170-23-015919
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- DEF 14A
- Filing date
- Apr 28, 2023
- Report date
- Jun 14, 2023
- Document
- janx_def_14a_2023.htm
- Size
- 2.7 MB